SCHEMBL3141845

SCHEMBL3141845

COC(=O)c1cc(CC(C)C)c(C(=O)OC)nn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
GSK3B P49841 1/20 0.40
NPSR1 Q6W5P4 1/20 0.37
MAPK1 P28482 2/20 0.36
TP53 P04637 2/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA2 P47869 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ACACB O00763 1/20 0.33
KDM4E B2RXH2 1/20 0.33
STAT3 P40763 1/20 0.33
HIF1A Q16665 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3141854 0.92 KDM4E (0.36) CDK4CCND1GSK3BNPSR1MAPK1
SCHEMBL3136957 0.83 HPGD (0.40) NPSR1TP53MAPTALDH1A1GAA
SCHEMBL4487940 0.82 HPGD (0.41) NPSR1TP53ALDH1A1
SCHEMBL13368926 0.79 NPC1 (0.40) NPSR1MAPK1TP53MAPTALDH1A1
SCHEMBL13755836 0.79 NPSR1 (0.38) NPSR1MAPK1MAPTGABRA2KDM4E
SCHEMBL13523524 0.77 NPSR1 (0.42) NPSR1MAPK1TP53MAPTALDH1A1
SCHEMBL3392295 0.77 ALDH1A1 (0.36) ALDH1A1GABRG2GABRB3GABRA2
SCHEMBL13751486 0.77 NPSR1 (0.42) NPSR1MAPK1TP53MAPTALDH1A1
SCHEMBL13523542 0.76 NPSR1 (0.35) NPSR1MAPK1TP53MAPTKDM4E
SCHEMBL13343759 0.76 NPSR1 (0.35) NPSR1MAPK1TP53MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113466-A1 OXAZOLE-PYRIDAZINE-OXAZOLE ALPHA-HELIX MIMETIC THE SCRIPPS RESEARCH INSTITUTE 2010-05-06 US disclosed
US-20100113466-A1 OXAZOLE-PYRIDAZINE-OXAZOLE ALPHA-HELIX MIMETIC THE SCRIPPS RESEARCH INSTITUTE 2010-05-06 US disclosed
WO-2010042758-A2 OXAZOLE-PYRIDAZINE-OXAZOLE ALPHA-HELIX MIMETIC THE SCRIPPS RESEARCH INSTITUTE (US) 2010-04-15 WO disclosed
US-20100022549-A1 ALPHA-HELIX MIMETIC WITH FUNCTIONALIZED PYRIDAZINE THE SCRIPPS RESEARCH INSTITUTE (US) 2010-01-28 US disclosed
WO-2010011864-A2 ALPHA-HELIX MIMETIC WITH FUNCTIONALIZED PYRIDAZINE THE SCRIPPS RESEARCH INSTITUTE (US) 2010-01-28 WO disclosed
WO-2010011864-A2 ALPHA-HELIX MIMETIC WITH FUNCTIONALIZED PYRIDAZINE THE SCRIPPS RESEARCH INSTITUTE (US) 2010-01-28 WO disclosed
US-20090298835-A1 NOVEL SCAFFOLDS FOR ALPHA-HELIX MIMICRY THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-03 US disclosed
US-20090298835-A1 NOVEL SCAFFOLDS FOR ALPHA-HELIX MIMICRY THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-03 US disclosed
US-20090298835-A1 NOVEL SCAFFOLDS FOR ALPHA-HELIX MIMICRY THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-03 US disclosed
US-7579350-B2 5-Isobutyl-6-4-isopropyl-4,5-dihydro-oxazol-2-yl)-pyridazin-3-yl]-piperidin-1-yl-methanone; mimetics of functionalized pyridazine derivatives having low molecular weight; alpha-helical binding ligands of natural receptors such as those of the peptide galanin or the protein Bcl THE SCRIPPS RESEARCH INSTITUTE (US) 2009-08-25 US disclosed
US-7579350-B2 5-Isobutyl-6-4-isopropyl-4,5-dihydro-oxazol-2-yl)-pyridazin-3-yl]-piperidin-1-yl-methanone; mimetics of functionalized pyridazine derivatives having low molecular weight; alpha-helical binding ligands of natural receptors such as those of the peptide galanin or the protein Bcl THE SCRIPPS RESEARCH INSTITUTE (US) 2009-08-25 US disclosed
US-20090197895-A1 OXAZOLE-PYRROLE-PIPERAZINE ALPHA-HELIX MIMETIC THE SCRIPPS RESEARCH INSTITUTE (US) 2009-08-06 US disclosed
US-20060205728-A1 Novel scaffolds for beta-helix mimicry THE SCRIPPS RESEARCH INSTITUTE (US) 2006-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205728-A1 Novel scaffolds for beta-helix mimicry HRH1, HEATR1, HSPH1 CDK4 3784/4885CCND1 4620/4885GSK3B 2295/4885
US-20100113466-A1 OXAZOLE-PYRIDAZINE-OXAZOLE ALPHA-HELIX MIMETIC OXA1L, H1-4, H1-5 CDK4 408/4885CCND1 2450/4885GSK3B 2968/4885
US-20090298835-A1 NOVEL SCAFFOLDS FOR ALPHA-HELIX MIMICRY HRH1, HEATR1, PLEKHA1 CDK4 3709/4885CCND1 4492/4885GSK3B 2875/4885
US-20090197895-A1 OXAZOLE-PYRROLE-PIPERAZINE ALPHA-HELIX MIMETIC OXA1L, OCIAD1, OCIAD2 CDK4 2085/4885CCND1 3820/4885GSK3B 2991/4885
US-20100022549-A1 ALPHA-HELIX MIMETIC WITH FUNCTIONALIZED PYRIDAZINE H1-4, H1-5, H1-3 CDK4 587/4885CCND1 2287/4885GSK3B 3431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.